The pills recalled are marketed under the name Lo/Ovral-28 and as generic Norgestrel/Ethinyl Estradiol as sold by Akrimax Pharmaceuticals. (A full list of lot numbers subject to recall is available here.) Pfizer told the Associated Press that tests revealed that quality control was at issue with the affected lots: “some packets of the drugs had too many active tablets, while others had too few.”
While there is no safety risk to the pills, users with packets that contain placebos instead of active pills are effectively — and unknowingly — not protected against pregnancy while taking those pills, and potentially for the month after as their bodies readjust. Users are encouraged to tell their doctors and return the affected pills to their pharmacies.
Megan Carpentier is the executive editor of Raw Story. She previously served as an associate editor at Talking Points Memo; the editor of news and politics at Air America; an editor at Jezebel.com; and an associate editor at Wonkette. Her published works include pieces for the Washington Post, the Washington Independent, Ms Magazine, RH Reality Check, the Women's Media Center, On the Issues, the New York Press, Bitch and Women's eNews.
Raw Story is a progressive news site that focuses on stories often ignored in the mainstream media. While giving coverage to the big stories of the day, we also bring our readers' attention to policy, politics, legal and human rights stories that get ignored in an infotainment culture driven solely by pageviews.
Founded in 2004, Raw Story reaches 9 million unique readers per month and serves more than 30 million pageviews.